title: FDA Approval of Extended-Release Oxycodone for Children With Severe Pain.
authors.affiliation: George Mason University, Fairfax, Virginia; and ytyang@gmu.edu.
authors.forename: Y Tony
authors.initials: YT
authors.lastname: Yang
authors.affiliation: University of South Carolina, Columbia, South Carolina.
authors.forename: Brian
authors.initials: B
authors.lastname: Chen
authors.affiliation: University of South Carolina, Columbia, South Carolina.
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
mesh_terms: D000293:Adolescent; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D059350:Chronic Pain / Q000188:drug therapy*; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D009293:Opioid-Related Disorders / Q000517:prevention & control; D010098:Oxycodone / Q000008:administration & dosage* / Q000627:therapeutic use; D012720:Severity of Illness Index; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D010098:Oxycodone